本专题系列探讨了基于诱导多能干细胞(iPSC)的免疫细胞疗法平台,旨在为癌症、病毒感染、自身免疫性疾病和移植并发症提供可再生、标准化的解决方案。本系列回顾了iPSC衍生的iNKT细胞、抗原呈递细胞(APC)、CD8+ T细胞和CD4+调节性T细胞(Treg),重点阐述了可扩展免疫疗法所面临的挑战和未来发展方向。
This Thematic Series explores iPSC-based platforms for immune-cell therapies, offering renewable, standardized solutions for cancer, viral infections, autoimmunity, and transplant complications. It reviews iPSC-derived iNKT cells, APCs, CD8+ T cells, and CD4+ Tregs, highlighting challenges and future directions for scalable immunotherapies.